Hypermarcas (OTCMKTS:HYPMY) Short Interest Update

Hypermarcas (OTCMKTS:HYPMY) was the recipient of a large increase in short interest in January. As of January 30th, there was short interest totaling 50,686 shares, an increase of 9,217.3% from the January 15th total of 544 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 27,516 shares, the days-to-cover ratio is presently 1.8 days. Based on an average daily volume of 27,516 shares, the days-to-cover ratio is presently 1.8 days. Approximately 0.0% of the shares of the stock are sold short.

Hypermarcas Price Performance

HYPMY stock traded up $0.03 during midday trading on Tuesday, reaching $4.46. 51,649 shares of the stock were exchanged, compared to its average volume of 21,276. The stock has a market capitalization of $2.82 billion, a PE ratio of 19.39 and a beta of 0.71. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.27 and a quick ratio of 0.84. The company has a fifty day moving average price of $4.51 and a 200 day moving average price of $4.43. Hypermarcas has a 52 week low of $3.10 and a 52 week high of $5.50.

Hypermarcas (OTCMKTS:HYPMY) last announced its earnings results on Wednesday, November 12th. The company reported $0.13 EPS for the quarter. The business had revenue of $408.83 million for the quarter. Hypermarcas had a return on equity of 6.89% and a net margin of 12.03%.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.